gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Melanoma in 5 studies
*Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akbari-Zadeh, H; Aminolroayaei, F; Birgani, FF; Maghsoudinia, F; Samani, RK; Shanei, A | 1 |
| Brasch, RC; Chaopathomkul, B; Cyran, CC; Fu, Y; Rogut, V; Shames, DM; Wendland, MF | 1 |
| Botta, M; Catanzaro, V; Filippi, M; Patrucco, D; Tei, L; Terreno, E | 1 |
| Aime, S; Arena, F; Gianolio, E; Singh, JB; Stefanìa, R | 1 |
| Allegrini, PR; Baumann, D; Becquet, M; Brecht, K; Brueggen, J; Ferretti, S; McSheehy, PM; Rausch, M; Rudin, M; Schaeffer, F; Schnell, C; Wood, J | 1 |
5 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Melanoma
| Article | Year |
|---|---|
Ultrasound responsive Gd-DOTA/doxorubicin-loaded nanodroplet as a theranostic agent for magnetic resonance image-guided controlled release drug delivery of melanoma cancer.
Topics: Animals; Cell Line, Tumor; Delayed-Action Preparations; Doxorubicin; Drug Delivery Systems; Heterocyclic Compounds; Magnetic Resonance Imaging; Melanoma; Mice; Organometallic Compounds; Precision Medicine; Theranostic Nanomedicine; Ultrasonography | 2022 |
Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Capsules; Cell Line, Tumor; Contrast Media; Drug Monitoring; Heterocyclic Compounds; Humans; Macromolecular Substances; Magnetic Resonance Imaging; Melanoma; Neovascularization, Pathologic; Organometallic Compounds; Polyethylene Glycols; Rats; Rats, Nude; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2013 |
First in vivo MRI study on theranostic dendrimersomes.
Topics: Animals; Cell Line, Tumor; Contrast Media; Dendrimers; Female; Glucocorticoids; Heterocyclic Compounds; Human Umbilical Vein Endothelial Cells; Humans; Magnetic Resonance Imaging; Melanoma; Mice; Mice, Inbred C57BL; Nanocapsules; Organometallic Compounds; Prednisolone; Theranostic Nanomedicine | 2017 |
β-Gal gene expression MRI reporter in melanoma tumor cells. Design, synthesis, and in vitro and in vivo testing of a Gd(III) containing probe forming a high relaxivity, melanin-like structure upon β-Gal enzymatic activation.
Topics: Animals; beta-Galactosidase; Cell Line, Tumor; Enzyme Activation; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Magnetic Resonance Imaging; Melanoma; Mice; Mice, Inbred C57BL; Monophenol Monooxygenase; Organometallic Compounds | 2011 |
PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Contrast Media; Female; Heterocyclic Compounds; Magnetic Resonance Imaging; Melanoma; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Organometallic Compounds; Phthalazines; Protein-Tyrosine Kinases; Pyridines; Vascular Endothelial Growth Factor A | 2005 |